logo
logo

Sanisure Announces The Acquisition Of A Leading Silicone Extrusion Facility In Twinsburg, Ohio

Dec 20, 2022•over 2 years ago

Acquiring Company

SaniSure

Acquired Company

Silicone Extrusion Facility

BiotechnologyPrivacy And SecurityManufacturing

Description

Sanisure, a leading, vertically-integrated player in the single- use bioprocessing technology space, is pleased to announce the acquisition of Medical Elastomer Development, Inc ("MED") a silicone extrusion facility from Q Holding, a 3i portfolio company. This state-of-the-art facility located in Twinsburg, Ohio, serves many industry- leading customers in both the medical device and bioprocessing markets.

Company Information

Company

SaniSure

About

The Best Home a Drug Can Get® Sanisure designs, develops, and manufactures single-use solutions for the bioprocessing industry including customized bottle assemblies, low-volume mixing solutions aseptic transfer systems, molded caps, flasks, tubes, and clamps. The business now operates six facilities in North America and Europe. Sanisure has longstanding relationships with leading biopharma and biotech Customers, exhibiting an impressive reputation for high-quality solutions and Customer service. In addition to its assembly offerings, Sanisure provides Customers several unique, IP-backed manufactured solutions such as Mixed4SureTM and Cap2V8TM to address our customers' most demanding applications. Logo - https://mma.prnewswire.com/media/1972129/Sanisure_Logo.jpg SOURCE Sanisure

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed